A comparison of the effects of adrenaline and noradrenaline in critically ill patients

Completed

• Conditions: Circulatory failure in critically ill patients; Circulatory System

• Registration Number: ISRCTN92846592
• Lead Sponsor: The St George Hospital - Dept of Intensive Care (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-03-07
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 250

Inclusion Criteria

Critically ill patients requiring a catacholamine infusion for cardiovascular support

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to resolution of circulatory failure to pre-morbid state from commencement of catecholamine.

Secondary Outcome Measures

Name	Time	Method
ICU length of stay and mortality, hospital mortality and 90-day mortality: degree of organ dysfunction during 28-day period (as determined by SOFA scores): cardiovascular, respiratory, renal, neurological, hepatic; and metabolic function.